| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A075C8A0 | NADH dehydrogenase subunit 5; | ND5; | NULL | 603 | human |
| A0A075X860 | NADH dehydrogenase subunit 4; | ND4; | NULL | 459 | human |
| A0A087WYS9 | Surfeit locus protein 1; | SURF1; | NULL | 191 | human |
| A0A075B6Z4 | Protein TRDJ4; Fragment; | TRDJ4; | NULL | 16 | human |
| A0A087WX80 | Laminin subunit alpha-2; | LAMA2; | NULL | 3121 | human |
| A0A077QPI2 | Kell blood group, metallo-endopeptidase; | KEL; | NULL | 732 | human |
| A0A087WV59 | Nuclear pore complex-interacting protein family member B11; | NPIPB11; | NULL | 250 | human |
| A0A068BFX3 | Truncated breast and ovarian cancer susceptibility protein 2; Fragment; | BRCA2; | NULL | 60 | human |
| A0A075X788 | NADH dehydrogenase subunit 4; | ND4; | NULL | 459 | human |
| A0A059RIE8 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4L; | NULL | 98 | human |
| A0A075B731 | Uncharacterized protein C16orf52; | C16orf52; | NULL | 114 | human |
| A0A076MKN9 | CDX2/AS; | CDX2; | NULL | 271 | human |
| A0A059QP19 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| Q7LE35 | OriP binding protein like gene product; | A-328A3.5; | NULL | 72 | human |
| A0A087WZK6 | Protein FAM69A; | FAM69A; | NULL | 369 | human |
| A0A087WV69 | Period circadian protein homolog 3; | PER3; | NULL | 1191 | human |
| A0A087WUU2 | Ubiquitin carboxyl-terminal hydrolase 12; | USP12; | NULL | 18 | human |
| A0A059QSG6 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| Q15309 | Rhodopsin; Fragment; | NULL | NULL | 51 | human |
| A0A068CCX5 | ATP synthase F0 subunit 6; | ATP6; | NULL | 226 | human |
